Key result
Adapted clinical pathways for transcatheter structural heart interventions, including same-day discharge, appear safe and feasible during pandemic-related resource constraints.
Answers are grounded in this paper and cite their sources.
This editorial highlights the need for dynamic innovation in clinical pathways, such as same-day discharge and telehealth, for transcatheter structural heart interventions adapted during the COVID-19 pandemic.
The COVID-19 pandemic forced structural heart programs to adapt processes of care in unprecedented ways. Clinical pathways for transcatheter structural heart interventions and the associated outcomes for different patient cohorts are described in two articles in this issue of Structural Heart. Tuttle and colleagues1 describe their experience early in the COVID-19 crisis (March through June 2020) when resources were significantly restricted. This cohort comprised mostly inpatients with refractory heart failure who underwent transcatheter aortic valve replacement (TAVR, n = 22) or percutaneous mitral valve intervention (PMVI, unspecified, n = 4) and had a higher risk of post procedure complications and high resource utilization.
No takes yet. Share an insight, caveat, or question.
Perpetua et al. (2021) conducted an editorial in Transcatheter structural heart interventions. Adapted clinical pathways (e.g., same-day discharge) vs. Standard clinical pathways was evaluated. Adapted clinical pathways for transcatheter structural heart interventions, including same-day discharge, appear safe and feasible during pandemic-related resource constraints.
Synapse has enriched 10 related papers. Consider them for comparative context: